Zimmer Biomet Holdings, Inc. (ZBH) — Analyst outlook / Analyst consensus target is. Based on 41 analyst ratings, the consensus is bullish — 17 Buy, 21 Hold, 3 Sell.
The consensus price target is $105.60 (low: $89.00, high: $122.00), representing an upside of 9.4% from the current price $96.52.
Analysts estimate Earnings Per Share (EPS) of $7.98 and revenue of $7.67B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $4.45 vs est $7.98 (missed -44.3%). 2025: actual $3.56 vs est $8.18 (missed -56.5%). Analyst accuracy: 0%.
ZBH Stock — 12-Month Price Forecast
$105.60
▲ +9.41% Upside
Average Price Target
Based on 41 Wall Street analysts offering 12-month price targets for Zimmer Biomet Holdings, Inc., the average price target is $105.60, with a high forecast of $122.00, and a low forecast of $89.00.
The average price target represents a +9.41% change from the last price of $96.52.
Highest Price Target
$122.00
Average Price Target
$105.60
Lowest Price Target
$89.00
ZBH Analyst Ratings
Hold
Based on 41 analysts giving stock ratings to Zimmer Biomet Holdings, Inc. in the past 3 months
EPS Estimates — ZBH
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $4.45
vs Est $7.98
▼ 79.4% off
2025
Actual $3.56
vs Est $8.18
▼ 129.7% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — ZBH
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $7.679B
vs Est $7.670B
▲ 0.1% off
2025
Actual $8.232B
vs Est $8.211B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
